GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
Currently predicting for Mon, 22 Apr 2024

Trading levels for MEIP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.34 2.67 %
R2 3.31 1.73 %
R1 3.29 1.15 %
Current price: 3.25
Support S1 3.23 -0.735 %
S2 3.21 -1.32 %
S3 3.18 -2.26 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.00 23.08 %
R2 3.83 17.85 %
R1 3.69 13.54 %
Current price 3.25
Support S1 3.20 -1.54%
S2 0 .
S3 0 .

MEIP Predictions History

3 years ago
JS predicted that MEIP for 2020-06-25 is going $4.01 (-6.53%)

3 years ago
JS predicted that MEIP for 2020-06-01 is going $3.52 (-15.99%)

4 years ago
JS predicted that MEIP for 2020-04-16 is going $2.29 (-1.29%)

6 years ago
JS predicted that MEIP for 2017-09-20 is going $2.70 (0.37%)

6 years ago
JS predicted that MEIP for 2017-06-05 is going $2.01 (-1.47%)

6 years ago
Jon predicted that MEIP for 2017-06-05 is going $1.99 (-2.45%)

6 years ago
JS predicted that MEIP for 2017-05-08 is going $1.61 (1.90%)

7 years ago
StockInvest predicted that MEIP for 2016-08-18 is going $1.97 (-2.96%)

7 years ago
StockInvest predicted that MEIP for 2016-08-15 is going $2.05 (0.99%)

Click to get the best stock tips daily for free!

About MEI Pharma

MEI Pharma MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymphoma, as well as in Phase Ib multi-arm trial to treat B-cell malignancies; and Voruciclib, an oral cycl... MEIP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT